Apobiologix
Mike Woolcock is a seasoned executive in the pharmaceutical and biotechnology industries, currently serving as Vice President of Commercial Operations at ApoPharma Inc. and Senior Vice President of Commercial Operations at Apobiologix. With a robust background that includes positions such as Principal at BioStrat Consulting Inc., Director of the Oncology Business Unit at Amgen, and Senior Manager at Apotex Inc. and Cortech Inc., Mike has extensive experience in drug development and regulatory affairs. Their career began at Procter & Gamble, where roles ranged from Sales Representative to Manager of Scientific Affairs. Mike holds a Bachelor of Science degree in Biochemistry and Genetics from La Trobe University.
This person is not in any teams
Apobiologix
Apobiologix is a member of the Apotex Group of Companies, the largest Canadian-owned, pharmaceutical company with sales in 115 countries across the world. Founded in 1974 by Dr. Barry Sherman, Apotex is one of the world’s leading suppliers of high-quality, affordable pharmaceutical products. The success of Apotex is founded on its culture of quality and its commitment to manufacturing safe and effective medicines, meeting strict regulatory standards and making healthcare accessible to millions of people worldwide.